Vera's IgAN approval kicks off competition with Otsuka

July 7, 2026 02:10 PM EDT PharmaFDA+ Ve­r­a's IgAN ap­proval kicks off com­pe­ti­tion with Ot­su­ka Nicole DeFeudis Senior Reporter Ve­ra Ther­a­peu­tics’ fu­sion pro­tein at­aci­cept got an ac­cel­er­at­ed ap­proval on Tues­day for a chron­ic au­toim­mune dis­ease that dam­ages the kid­neys. The drug Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER